Marshall Wace, LLP Pacira Bio Sciences, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 524,949 shares of PCRX stock, worth $10.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

524,949

Previous 971,143 45.95%

Holding current value

$10.4 Million

Previous $27.8 Million 71.55%

% of portfolio

0.01%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $5.22 Million - $12.7 Million	-446,194 Reduced 45.95%	524,949 $7.91 Million
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $4.07 Million - $5.04 Million	159,791 Added 19.69%	971,143 $27.8 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $9.17 Million - $11.7 Million	331,159 Added 68.96%	811,352 $23.7 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $143,496 - $187,058	-5,452 Reduced 1.12%	480,193 $16.2 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $2.99 Million - $3.9 Million	97,348 Added 25.07%	485,645 $14.9 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $2.5 Million - $3.28 Million	69,136 Added 21.66%	388,297 $15.6 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $6.89 Million - $8.41 Million	193,804 Added 154.6%	319,161 $13 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $3.15 Million - $4.73 Million	82,396 Added 191.79%	125,357 $4.84 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $1.26 Million - $1.45 Million	24,638 Added 134.46%	42,961 $2.29 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $943,451 - $1.5 Million	18,323 New	18,323 $1.07 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $12.3 Million - $15.7 Million	-205,322 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $9.13 Million - $11.8 Million	190,381 Added 1274.22%	205,322 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $816,376 - $915,883	14,941 New	14,941 $837,000
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $1.81 Million - $2.14 Million	-30,624 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $1.82 Million - $2.41 Million	30,624 New	30,624 $2.15 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $558,713 - $997,421	-19,673 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $9.2 Million - $11.9 Million	-253,489 Reduced 92.8%	19,673 $891,000
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $9.74 Million - $12.3 Million	273,162 New	273,162 $10.4 Million

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $911M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Pacira Bio Sciences, Inc. Transaction History